Literature DB >> 9031071

Serum levels of adhesion molecules and cytokines in patients with acute leukaemia.

O Bruserud1, A Halstensen, E Peen, C O Solberg.   

Abstract

The cytokine network and the adhesion molecule system are intercellular signal pathways. The cytokine effects are modulated in vivo by soluble cytokine antagonists, whereas the cell to cell contact mediated by adhesion molecules and their ligands may be blocked by the soluble forms of the adhesion molecules. The cytokine network is important for proliferation and cytokine secretion by acute leukaemia blasts, and membrane-bound adhesion molecules are important for blast interactions with neighbouring cells of the in vivo microenvironment. Both these signal systems are operative during the period of cytopenia following intensive chemotherapy for acute leukaemia. In the present review, we discuss the influence of disease status, chemotherapy and complicating infections on serum levels of cytokines and soluble adhesion molecules in acute leukaemia patients. We have demonstrated increased serum levels of both cytokines and cytokine antagonists in acute leukaemia patients with complicating bacterial infections during chemotherapy-induced cytopenia. Serum levels of the selectin adhesion molecules were decreased during bacterial infections in leukopenic patients compared to healthy individuals. In contrast, the intercellular adhesion molecule-1 response and the cytokine/cytokine antagonist responses were qualitatively similar to responses seen in previously healthy individuals with serious bacterial infections.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 9031071     DOI: 10.3109/10428199609054849

Source DB:  PubMed          Journal:  Leuk Lymphoma        ISSN: 1026-8022


  6 in total

Review 1.  The possible diagnostic and prognostic use of systemic chemokine profiles in clinical medicine—the experience in acute myeloid leukemia from disease development and diagnosis via conventional chemotherapy to allogeneic stem cell transplantation.

Authors:  Håkon Reikvam; Hanne Fredly; Astrid Olsnes Kittang; Oystein Bruserud
Journal:  Toxins (Basel)       Date:  2013-02-18       Impact factor: 4.546

2.  Systemic levels of the endothelium-derived soluble adhesion molecules endocan and E-selectin in patients with suspected deep vein thrombosis.

Authors:  Knut Anders Mosevoll; Roald Lindås; Oystein Wendelbo; Oystein Bruserud; Håkon Reikvam
Journal:  Springerplus       Date:  2014-09-30

3.  Preconditioning serum levels of endothelial cell-derived molecules and the risk of posttransplant complications in patients treated with allogeneic stem cell transplantation.

Authors:  Roald Lindås; Tor Henrik Andersson Tvedt; Kimberley Joanne Hatfield; Håkon Reikvam; Oystein Bruserud
Journal:  J Transplant       Date:  2014-10-08

4.  The Systemic Profile of Soluble Immune Mediators in Patients with Myelodysplastic Syndromes.

Authors:  Astrid Olsnes Kittang; Kristoffer Sand; Annette Katharina Brenner; Kristin Paulsen Rye; Øystein Bruserud
Journal:  Int J Mol Sci       Date:  2016-07-05       Impact factor: 5.923

Review 5.  Endocan in Acute Leukemia: Current Knowledge and Future Perspectives.

Authors:  Håkon Reikvam; Kimberley Joanne Hatfield; Øystein Wendelbo; Roald Lindås; Philippe Lassalle; Øystein Bruserud
Journal:  Biomolecules       Date:  2022-03-24

Review 6.  The snake venom rhodocytin from Calloselasma rhodostoma- a clinically important toxin and a useful experimental tool for studies of C-type lectin-like receptor 2 (CLEC-2).

Authors:  Øyvind Bruserud
Journal:  Toxins (Basel)       Date:  2013-04-17       Impact factor: 4.546

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.